David M. Marks | Psychiatrist.com

Original Research

History of Depressive and Anxiety Disorders and Paroxetine Response in Patients With Irritable Bowel Syndrome: Post Hoc Analysis From a Placebo-Controlled Study

Original Research

An Open-Label, Rater-Blinded, Flexible-Dose, 8-Week Trial of Escitalopram in Patients With Major Depressive Disorder With Atypical Features

Article

A Double-Blind, Placebo-Controlled, Parallel-Group Pilot Study of Milnacipran for Chronic Radicular Pain (Sciatica) Associated With Lumbosacral Disc Disease

Here, review results from a 10-week study that compared the pain-relieving effects of milnacipran, an SNRI, to that of placebo in patients with lumbosacral disc disease. Nerve pain in...

Brief Report

Durability of Benefit From Repeated Intravenous Lidocaine Infusions in Fibromyalgia Patients: A Case Series and Literature Review

The authors of this Brief Report tell you about the effective use of serial intravenous lidocaine infusions for the chronic management of 3 patients with fibromyalgia. They describe the...

Article

Effects of Milnacipran on Neurocognition, Pain, and Fatigue in Fibromyalgia: A 13-Week, Randomized, Placebo-Controlled, Crossover Trial

Is milnacipran a safe and effective treatment for improving cognitive function in fibromyalgia? See these study results to find out.

Article

Open-Label Milnacipran for Patients With Persistent Knee Pain 1 Year or Longer After Total Knee Arthroplasty: A Pilot Study

Researchers from Duke University conducted a small study of the drug milnacipran in patients who continued to experience knee pain for a year or more despite having an otherwise...